Aravive, Inc. (ARAV:NASDAQ) jumped higher at $0.17, representing a gain of 46.1%. The stock got featured on our News Catalysts scanner on Wed, Aug 02, 2023 at 04:53 PM in the 'BIOTECH' category. From Wed, Aug 16, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Mar 21, 2023 at $2.46 with a volume of 1M+.
About Aravive, Inc. (ARAV:NASDAQ)
Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.
Top 10 Gainers:
- AgileThought Inc. (AGIL:NASDAQ), 83.03%
- IronNet Inc. (IRNT:NYSE), 75%
- Tingo Group Inc Com (TIO:NASDAQ), 64.76%
- F45 Training Holdings Inc. (FXLV:NYSE), 60%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 56.65%
- Aravive, Inc. (ARAV:NASDAQ), 46.12%
- AEON Biopharma Inc. Class A (AEON:NYSEMKT), 42.29%
- SeqLL Inc. (SQL:NASDAQ), 40.8%
- PAVmed Inc. (PAVM:NASDAQ), 35.76%
- Digital Brands Group Inc. (DBGI:NASDAQ), 34.83%